In patients with type 2 diabetes mellitus ( T2DM ) , blocking of the renin-angiotensin-aldosterone system ( RAAS ) has demonstrated efficacy in lowering blood pressure ( BP ) and urinary albumin excretion rate ( UAER ) .
